Literature DB >> 12429213

Heterogeneity of nigral and cortical Lewy bodies differentiated by amplified triple-labeling for alpha-synuclein, ubiquitin, and thiazin red.

Masaki Sakamoto1, Toshiki Uchihara, Masaharu Hayashi, Ayako Nakamura, Etsuko Kikuchi, Toshio Mizutani, Hidehiro Mizusawa, Shunsaku Hirai.   

Abstract

Alpha-synuclein(alpha-S) and ubiquitin(Ub) are constituents of the Lewy bodies (LBs), composed of fibrillary structures. To clarify morphological heterogeneity of LBs, we looked for localization of these epitopes in relation to fibrillary structure possibly detectable by a fluorochrome, thiazin red (TR). On the sections of the substantia nigra (SN) and the cingulate gyrus (CG) obtained from Parkinson's disease brains, double amplification by CARD fluorescent immunohistochemistry with anti-alpha-S monoclonal (LB509) and anti-Ub polyclonal antibodies was performed, followed by staining with TR. These triple-labeled images were captured by a confocal laser microscope and subsequently stained with Campbell-Switzer method, a silver staining specific for LBs. Staining profiles of LBs were different between those in the SN and in the CG. Immunolabeling either with the anti-alpha-S or anti-Ub antibody was diffuse without halo structure in LBs of CG. In addition to this diffuse staining, a lot of LBs of SN exhibited a halo structure immunopositive for alpha-S and Ub, probably representing later stages of LB evolution. Irrespective of the presence of this halo structure, the TR signal was always concentrated in the center of LBs, as the silver-stained material was, suggesting that fibrillary components in the central portion of LBs undergo some conformational changes detectable by TR and the silver-staining. This technique reveals different epitopes in relation to LB evolution in vivo. Heterogeneity in staining profile of LBs, as clarified by this method, may represent evolutional changes of LBs, related to conformational states of their constituents.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12429213     DOI: 10.1006/exnr.2002.7961

Source DB:  PubMed          Journal:  Exp Neurol        ISSN: 0014-4886            Impact factor:   5.330


  10 in total

1.  Lewy bodies.

Authors:  Clifford W Shults
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-31       Impact factor: 11.205

2.  Autophagy modulates SNCA/α-synuclein release, thereby generating a hostile microenvironment.

Authors:  Anne-Maria Poehler; Wei Xiang; Philipp Spitzer; Verena Elisabeth Luise May; Holger Meixner; Edward Rockenstein; Oldriska Chutna; Tiago Fleming Outeiro; Juergen Winkler; Eliezer Masliah; Jochen Klucken
Journal:  Autophagy       Date:  2014       Impact factor: 16.016

3.  Distinct mechanisms of axonal globule formation in mice expressing human wild type α-synuclein or dementia with Lewy bodies-linked P123H β-synuclein.

Authors:  Akio Sekigawa; Masayo Fujita; Kazunari Sekiyama; Yoshiki Takamatsu; Taku Hatano; Edward Rockenstein; Albert R La Spada; Eliezer Masliah; Makoto Hashimoto
Journal:  Mol Brain       Date:  2012-09-26       Impact factor: 4.041

4.  Synchrotron FTIR micro-spectroscopy for structural analysis of Lewy bodies in the brain of Parkinson's disease patients.

Authors:  Katsuya Araki; Naoto Yagi; Yuka Ikemoto; Hisashi Yagi; Chi-Jing Choong; Hideki Hayakawa; Goichi Beck; Hisae Sumi; Harutoshi Fujimura; Taro Moriwaki; Yoshitaka Nagai; Yuji Goto; Hideki Mochizuki
Journal:  Sci Rep       Date:  2015-12-01       Impact factor: 4.379

5.  Distinct pattern of enteric phospho-alpha-synuclein aggregates and gene expression profiles in patients with Parkinson's disease.

Authors:  Martina Barrenschee; Dimitri Zorenkov; Martina Böttner; Christina Lange; François Cossais; Amelie Bernadette Scharf; Günther Deuschl; Susanne A Schneider; Mark Ellrichmann; Annette Fritscher-Ravens; Thilo Wedel
Journal:  Acta Neuropathol Commun       Date:  2017-01-05       Impact factor: 7.801

6.  The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration.

Authors:  Anne-Laure Mahul-Mellier; Johannes Burtscher; Niran Maharjan; Laura Weerens; Marie Croisier; Fabien Kuttler; Marion Leleu; Graham W Knott; Hilal A Lashuel
Journal:  Proc Natl Acad Sci U S A       Date:  2020-02-19       Impact factor: 11.205

Review 7.  Alpha-synuclein research: defining strategic moves in the battle against Parkinson's disease.

Authors:  Luis M A Oliveira; Thomas Gasser; Robert Edwards; Markus Zweckstetter; Ronald Melki; Leonidas Stefanis; Hilal A Lashuel; David Sulzer; Kostas Vekrellis; Glenda M Halliday; Julianna J Tomlinson; Michael Schlossmacher; Poul Henning Jensen; Julia Schulze-Hentrich; Olaf Riess; Warren D Hirst; Omar El-Agnaf; Brit Mollenhauer; Peter Lansbury; Tiago F Outeiro
Journal:  NPJ Parkinsons Dis       Date:  2021-07-26

Review 8.  Molecular pathology of Lewy body diseases.

Authors:  Katrin Beyer; Montserrat Domingo-Sàbat; Aurelio Ariza
Journal:  Int J Mol Sci       Date:  2009-02-26       Impact factor: 5.923

Review 9.  Models of α-synuclein aggregation in Parkinson's disease.

Authors:  Rosa Giráldez-Pérez; Mónica Antolín-Vallespín; María Muñoz; Amelia Sánchez-Capelo
Journal:  Acta Neuropathol Commun       Date:  2014-12-13       Impact factor: 7.801

10.  Analysis of α-Synuclein Pathology in PINK1 Knockout Rat Brains.

Authors:  Rose B Creed; Matthew S Goldberg
Journal:  Front Neurosci       Date:  2019-01-09       Impact factor: 4.677

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.